comparemela.com

Latest Breaking News On - Nasdaq omga - Page 2 : comparemela.com

Omega Therapeutics Inc (OMGA) Stock: Navigating the Market Volatility

The stock of Omega Therapeutics Inc (OMGA) has seen a -0.67% decrease in the past week, with a -31.16% drop in the past month, and a -71.81% decrease in the past quarter. The volatility ratio for the week is 13.27%, and the volatility levels for the past 30 days are at 15.70% for OMGA. The simple mo

Omega Therapeutics Inc (OMGA) Shares Down Despite Recent Market Volatility

Omega Therapeutics Inc (NASDAQ: OMGA) has experienced a decline in its stock price by -11.63 compared to its previous closing price of 1.72. However, the company has seen a fall of -15.08% in its stock price over the last five trading days. GlobeNewsWire reported 2023-10-04 that CAMBRIDGE, Mass., Oc

Omega Therapeutics Presents New Preclinical Data Supporting

Combination of a MYC-targeting epigenomic controller with immune checkpoint or EGFR inhibitor enhanced anti-tumor activity in models of NSCLC.

Omega Therapeutics Inc (OMGA) vs Its Peers: A Comparison

Additionally, the 36-month beta value for OMGA is 1.00. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.” The average price predicted by analysts

Omega Therapeutics to Participate in Two Upcoming Investor

CAMBRIDGE, Mass., Sept. 21, 2023 (GLOBE NEWSWIRE) Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.